Skip to main content
. 2018 Jan 16;68(667):e139–e145. doi: 10.3399/bjgp18X694613

Table 3.

Analysis of covariance of endline HbA1c of the intervention and control groupsa

Group HbA1c baseline (95% CI) HbA1c endline (95% CI) Estimated effect size (CI) F P-value
Intervention 6.84 (6.40 to 7.27) 6.26 (6.19 to 6.33) −0.74 (−1.32 to −0.02) 12.92 0.015b
Control 6.36 (5.99 to 6.73) 6.82 (6.69 to 6.95)
a

Dependent variable: HbA1c endline. (HbA1c = glycosylated haemoglobin).

b

The endline HbA1c was compared between the treatment groups adjusting for baseline HbA1c using ANCOVA.